BMO Capital lowered the firm’s price target on Ryan Specialty (RYAN) to $66 from $70 and keeps an Outperform rating on the shares. Despite the positive stock reaction to the company’s Q3 earnings beat, the firm’s estimates are moving lower as it embeds tempered margin expectations while seizing on hiring opportunities to underpin growth in a slowing overall environment and not fully run-rating the organic upside surprise, the analyst tells investors in a research note. In the near term, negative seasonality could cause growthy investors to react negatively, the firm added.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $63 from $71 at Goldman Sachs
- Ryan Specialty price target lowered to $65 from $73 at Keefe Bruyette
- Ryan Specialty Group’s Earnings Call: Growth Amid Challenges
- Ryan Specialty Group: Strong Organic Growth and Strategic Investments Justify Buy Rating
- Ryan Specialty Group Reports Strong Q3 2025 Results